Opportunity Information: Apply for PA 14 224

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Long Term Retention in Care for U.S. Substance Using Populations (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on May 15, 2014 and posted on May 14, 2014.
  • Applicants must submit their applications by May 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) City or township governments Small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public and State controlled institutions of higher education County governments For profit organizations other than small businesses Special district governments Public housing authorities/Indian housing authorities.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Apply for PA 14 224

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Long Term Retention in Care for U.S. Substance Using Populations (R01)" (Funding Opportunity Number PA-14-224) is a National Institutes of Health (NIH) discretionary grant that supported research aimed at one central public health problem: keeping people living with HIV engaged in continuous, long-term medical care, particularly when substance use is part of their lives. The FOA is grounded in a practical reality of HIV care in the United States: without a cure, HIV becomes a lifelong condition, and the benefits of antiretroviral therapy depend heavily on consistent clinical follow-up, medication access and adherence support, and ongoing monitoring. For people who use substances, staying connected to care can be harder because of issues like unstable housing, mental health comorbidities, stigma, criminal-legal involvement, and fragmented health and social service systems. This announcement therefore emphasized research that can strengthen long-term retention in care and, as a result, improve sustained viral suppression, which is a key marker of successful HIV treatment and also a major driver of reduced HIV transmission at the population level.

This was an R01 mechanism, meaning it was intended to fund substantial, hypothesis-driven research projects rather than small pilots. While the short description highlights "long term retention in care leading to sustained viral suppression among substance abusers," the broader implication is that NIH was looking for studies that go beyond short-term linkage or initial engagement and instead examine what helps people remain in care year after year. In practical terms, that can include developing and testing interventions, identifying modifiable barriers and facilitators of retention, evaluating service delivery models that integrate HIV care with substance use treatment, and generating evidence that health systems and community programs can use to reduce drop-off across the HIV care continuum. The focus on sustained viral suppression also signals an interest in outcomes that matter clinically and epidemiologically, not just clinic attendance, since viral suppression is the endpoint that reflects effective, ongoing treatment.

Administratively, the opportunity was categorized under Education and Health and listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs), aligning it strongly with NIH research priorities at the intersection of HIV and substance use. It did not require cost sharing or matching, which reduces barriers for many applicants and is typical for NIH research grants. The FOA was posted in mid-May 2014 (Posted Date: May 14, 2014; Creation Date: May 15, 2014) and ultimately closed on May 7, 2017, with an archive date of June 7, 2017. In other words, it is no longer open, but it describes the kind of research NIH sought during that period and can still be useful as a guide to the research themes and expectations NIH has often maintained in this area.

Eligibility was broad and included many types of U.S.-based organizations. Eligible applicants encompassed public and private institutions of higher education, independent school districts, nonprofit organizations (both with and without 501(c)(3) status), small businesses, for-profit organizations (other than small businesses), and multiple levels of government, including city/township, county, state, special district governments, and certain housing authorities. The FOA also explicitly included tribal governments (federally recognized) and tribal organizations, reflecting an intent to allow participation by tribal entities and to support research relevant to Native communities. Additional eligible applicants listed in the announcement included a range of designated institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. At the same time, the FOA clearly limited applications to domestic entities: non-U.S. (foreign) institutions were not eligible to apply, non-domestic components of U.S. organizations were not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) were not allowed.

In short, PA-14-224 was designed to build a stronger evidence base for keeping U.S. populations living with HIV and affected by substance use consistently engaged in care over the long term, with the explicit goal of achieving and maintaining viral suppression. It supported rigorous research projects capable of producing actionable findings for clinics, health systems, and community programs trying to close persistent retention gaps and improve lifelong HIV outcomes among people who use substances. For technical issues accessing the full announcement, NIH directed applicants to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Frequently Asked Questions (FAQs)

What is the "Long Term Retention in Care for U.S. Substance Using Populations (R01)" grant opportunity?

It is an NIH discretionary research funding opportunity (Funding Opportunity Number PA-14-224) that supported studies focused on a central public health problem: helping people living with HIV stay engaged in continuous, long-term medical care when substance use is part of their lives.

What public health problem was this FOA trying to address?

The FOA targeted long-term retention in HIV care for U.S. populations affected by substance use. The underlying concern is that HIV is a lifelong condition without a cure, and the benefits of antiretroviral therapy depend on consistent clinical follow-up, medication access and adherence support, and ongoing monitoring over time.

Why did the FOA emphasize "long-term retention" rather than short-term linkage to care?

The announcement emphasized research that goes beyond initial linkage or early engagement and instead examines what helps people remain in care year after year. The intention was to reduce drop-off across the HIV care continuum over the long run.

Who was the intended population of interest in this FOA?

The FOA focused on U.S. populations living with HIV where substance use is relevant to maintaining continuous care. It highlighted that retention can be especially challenging for people who use substances due to factors like unstable housing, mental health comorbidities, stigma, criminal-legal involvement, and fragmented health and social service systems.

What kinds of outcomes did NIH want applicants to focus on?

While retention in care was the central theme, the FOA explicitly connected long-term retention to sustained viral suppression. Viral suppression was presented as a key marker of successful HIV treatment and a major driver of reduced HIV transmission at the population level.

What is the significance of sustained viral suppression in this opportunity?

The focus on sustained viral suppression signaled interest in outcomes that matter clinically and epidemiologically, not only measures like clinic attendance. Viral suppression reflects effective, ongoing treatment over time.

What research approach or project scope did the R01 mechanism imply?

This was an R01 mechanism, which is intended for substantial, hypothesis-driven research projects rather than small pilot projects. In practical terms, the FOA pointed toward rigorous studies capable of producing actionable findings for real-world HIV care settings.

What types of research topics were emphasized as relevant under this FOA?

Based on the description provided, emphasized topics included: developing and testing interventions to strengthen retention, identifying modifiable barriers and facilitators of retention, evaluating service delivery models that integrate HIV care with substance use treatment, and producing evidence that clinics, health systems, and community programs can use to reduce long-term disengagement from care.

How does substance use affect HIV retention in care, according to the FOA description?

The FOA highlighted that staying connected to care can be harder for people who use substances because of issues such as unstable housing, mental health comorbidities, stigma, criminal-legal involvement, and fragmented health and social service systems.

What federal program area and CFDA listing was associated with this opportunity?

The opportunity was categorized under Education and Health and listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs), aligning it with NIH research priorities at the intersection of HIV and substance use.

Was cost sharing or matching required?

No. The FOA did not require cost sharing or matching.

When was this FOA posted, and when did it close?

The FOA was posted in mid-May 2014 (Posted Date: May 14, 2014; Creation Date: May 15, 2014). It closed on May 7, 2017, and was archived on June 7, 2017.

Is this funding opportunity still open for applications?

No. It closed on May 7, 2017 and was archived on June 7, 2017.

If it is closed, why might this FOA still be useful?

Even though it is no longer open, it describes the kinds of research NIH sought during that period and can still serve as a guide to the research themes and expectations NIH has often maintained in this area.

Who was eligible to apply?

Eligibility was broad and included many types of U.S.-based organizations, such as public and private institutions of higher education, independent school districts, nonprofit organizations (with or without 501(c)(3) status), small businesses, for-profit organizations (other than small businesses), and multiple levels of government (city/township, county, state, special district governments), including certain housing authorities.

Were tribal governments and tribal organizations eligible?

Yes. The FOA explicitly included tribal governments (federally recognized) and tribal organizations, reflecting an intent to allow participation by tribal entities and to support research relevant to Native communities.

Did the FOA name any specific institution types as eligible applicants?

Yes. The announcement explicitly listed designated institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also included faith-based and community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies.

Were foreign (non-U.S.) organizations eligible to apply?

No. The FOA limited applications to domestic entities. Non-U.S. (foreign) institutions were not eligible to apply.

Could a U.S. organization include a non-domestic component or foreign component in the application?

No. The FOA stated that non-domestic components of U.S. organizations were not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) were not allowed.

What practical impact was NIH trying to achieve through this research funding?

The FOA aimed to build a stronger evidence base for keeping people living with HIV and affected by substance use consistently engaged in care over the long term, with the explicit goal of achieving and maintaining viral suppression. The intent was to support findings that clinics, health systems, and community programs could use to close persistent retention gaps and improve lifelong HIV outcomes.

Where were applicants directed for technical issues accessing the full announcement?

For technical issues accessing the full announcement, NIH directed applicants to the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Sheboygan River Area of Concern Habitat Restoration

Previous opportunity: Long Term Retention in Care for U.S. Substance Using Populations (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 14 224

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 14 224) also looked into and applied for these:

Funding Opportunity
Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain (R01) Apply for PAR 14 225

Funding Number: PAR 14 225
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R21/R33) Apply for PAR 14 230

Funding Number: PAR 14 230
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R33) Apply for PAR 14 231

Funding Number: PAR 14 231
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $225,000
National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 14 234

Funding Number: PAR 14 234
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Collaborative Research Projects to Enhance Applicability of Mouse Models for Translational Research (Collaborative R01) Apply for PAR 14 240

Funding Number: PAR 14 240
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $450,000
Research Projects to Enhance Applicability of Mouse Models for Translational Research (R01) Apply for PAR 14 241

Funding Number: PAR 14 241
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $450,000
Oncology Models Forum (U24) Apply for PAR 14 239

Funding Number: PAR 14 239
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $750,000
Limited Competition Biospecimen Banks to Support NCI Clinical Trials Network (NCTN) (U24) Apply for RFA CA 14 501

Funding Number: RFA CA 14 501
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $11,750,000
Molecular and Cellular Characterization of Screen Detected Lesions Coordinating Center and Data Management Group (U01) Apply for RFA CA 14 011

Funding Number: RFA CA 14 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000
Molecular and Cellular Characterization of Screen Detected Lesions (U01) Apply for RFA CA 14 010

Funding Number: RFA CA 14 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Innovation Corps (I Corps) Team Training Pilot Program for NIH Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grantees (Admin Supp) Apply for PAR 14 261

Funding Number: PAR 14 261
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $25,000
Outstanding Investigator Award (R35) Apply for PAR 14 267

Funding Number: PAR 14 267
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $600,000
The National Drug Abuse Treatment Clinical Trials Network (UG1) Apply for RFA DA 15 008

Funding Number: RFA DA 15 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Connectomes Related to Human Disease (U01) Apply for PAR 14 281

Funding Number: PAR 14 281
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01) Apply for RFA DA 15 011

Funding Number: RFA DA 15 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21) Apply for RFA DA 15 012

Funding Number: RFA DA 15 012
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,000,000
Innovative Research in Cancer Nanotechnology (IRCN) (U01) Apply for PAR 14 285

Funding Number: PAR 14 285
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $450,000
Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) Apply for RFA CA 14 013

Funding Number: RFA CA 14 013
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School and/or College Attending Youth (U01) Apply for RFA DA 15 010

Funding Number: RFA DA 15 010
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $1,000,000
Arts Based Approaches in Palliative Care for Symptom Management (R01) Apply for PAR 14 294

Funding Number: PAR 14 294
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 14 224", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.